Adaptive Biotechnologies Corp
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report2 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+7.18%
vs ±15.2% implied · ×0.47
shaded = implied · ▲▼ = realized
Adaptive Biotechnologies has 2 disclosed suppliers and 4 disclosed customers in SEC filings.
Adaptive Biotechnologies Corp
26.60
SentenceEarly work by Dr. Robins with Fred Hutch led to discoveries around immunosequencing methods and tools covered by multiple patents and patent applications in the U.S. and abroad which we exclusively licensed.
ADPT 10-Kaccession 0001193125-26-076902
SentenceIn December 2025, we entered into two non-exclusive agreements with Pfizer Inc. ("Pfizer") to leverage proprietary TCR discovery platform and its large‑scale immune receptor–antigen mapping datasets to accelerate therapeutic research in rheumatoid arthritis ("RA") and broader immunology applications.
SentenceclonoSEQ MRD testing has now been enabled in 173 sites on the Epic System Corporation's ("Epic") comprehensive electronic medical record ("EMR") system, through Flatiron Health, Inc.'s ("Flatiron") OncoEMR ® and on other EMRs to enable easier test workflow and follow-up to facilitate more routine access to patients.
ADPT 10-Kaccession 0001193125-26-076902
SentenceclonoSEQ MRD testing has now been enabled in 173 sites on the Epic System Corporation's ("Epic") comprehensive electronic medical record ("EMR") system, through Flatiron Health, Inc.'s ("Flatiron") OncoEMR ® and on other EMRs to enable easier test workflow and follow-up to facilitate more routine access to patients.
ADPT 10-Kaccession 0001193125-26-076902
SentenceOn August 13, 2025, our worldwide collaboration and license agreement with Genentech, Inc. ("Genentech") (the "Genentech Agreement") was terminated, with termination effective February 9, 2026.
ADPT 10-Kaccession 0001193125-26-076902
Linked news
Expected move
Inputs8Q avg ±10.8%·×1.74·rich
straddle ±18.8%
spot 26.64exp Nov 20ATM strike 25ATM straddle 5.90IV 117%